Literature DB >> 6091827

Leukotriene B4-like material in scale of psoriatic skin lesions.

S D Brain, R D Camp, F M Cunningham, P M Dowd, M W Greaves, A K Black.   

Abstract

Acidic lipid extracts of scale from the lesions of the skin disease, psoriasis, were purified by straight phase high performance liquid chromatography (h.p.l.c.). Assay of fractions by an agarose microdroplet chemokinesis method showed the presence of biologically active material that coeluted with standard leukotriene B4 (LTB4). LTB4-like chemokinetic activity was also detected in fractions collected on reversed phase h.p.l.c. of psoriatic scale extracts that were initially purified by straight phase h.p.l.c. No LTB4-like activity was detected after similar purification of scale obtained by abrasion of large areas of normal skin. The LTB4-like material found in extracts of psoriatic scale may play a role in the pathogenesis of the neutrophil infiltrate which characterizes psoriasis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091827      PMCID: PMC1987167          DOI: 10.1111/j.1476-5381.1984.tb10148.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Psoriasis and leukotriene B4.

Authors:  S D Brain; R D Camp; P M Dowd; A K Black; P M Woollard; A I Mallet; M W Greaves
Journal:  Lancet       Date:  1982-10-02       Impact factor: 79.321

2.  Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets.

Authors:  S R Turner; J A Tainer; W S Lynn
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

3.  Earliest clinical and histological changes in psoriasis.

Authors:  O Chowaniec; S Jabłońska; E H Beutner; M Proniewska; M Jarzabek-Chorzelska; G Rzesa
Journal:  Dermatologica       Date:  1981

4.  Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

Authors:  P Borgeat; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

5.  Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species.

Authors:  R M Palmer; R J Stepney; G A Higgs; K E Eakins
Journal:  Prostaglandins       Date:  1980-08

6.  The identification of hydroxy fatty acids in psoriatic skin.

Authors:  R D Camp; A I Mallet; P M Woollard; S D Brain; A K Black; M W Greaves
Journal:  Prostaglandins       Date:  1983-09

7.  Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis.

Authors:  S Hammarström; M Hamberg; B Samuelsson; E A Duell; M Stawiski; J J Voorhees
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

8.  The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemokinesis.

Authors:  M J Smith; J R Walker
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

9.  Generation of unique mono-hydroxy-eicosatetraenoic acids from arachidonic acid by human neutrophils.

Authors:  E J Goetzl; F F Sun
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

  9 in total
  10 in total

1.  Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.

Authors:  P M Dowd; A K Black; P W Woollard; M W Greaves
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  The inflammatory response of rabbit skin to topical arachidonic acid and its pharmacological modulation.

Authors:  D Aked; S J Foster; A Howarth; M E McCormick; H C Potts
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

3.  Psoriatic skin lesions contain a novel lipid neutrophil chemokinetic compound which is distinct from known chemoattractant eicosanoids.

Authors:  R D Camp; F M Cunningham; N J Fincham; M W Greaves; A Kobza Black; A I Mallet; P M Woollard
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

4.  Leukotrienes in disease. Implications for drug development.

Authors:  G A Higgs; S Moncada
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

5.  Characterization of two dipeptidases purified from hepatic schistosome egg granulomas in mice. Leukotriene D4 hydrolases of granulomatous tissue.

Authors:  N Sato; Y Ito; T Iida; K Fukuyama; W L Epstein
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

6.  Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids.

Authors:  C Miller; R Y Yamaguchi; V A Ziboh
Journal:  Lipids       Date:  1989-12       Impact factor: 1.880

7.  Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid.

Authors:  K B Bacon; R D Camp; F M Cunningham; P M Woollard
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

8.  Inhibition of ionophore-stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids.

Authors:  R D Camp; N J Fincham
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

9.  Metabolic disposition of leukotriene B4 (LTB4) and oxidation-resistant analogues of LTB4 in conscious rabbits.

Authors:  S Marleau; N Dallaire; P E Poubelle; P Borgeat
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

10.  The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.

Authors:  J M Schröder
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.